Panacea Life Sciences Holdings, Inc. Increase (Decrease) in Derivative Liabilities
Panacea Life Sciences Holdings, Inc. (PLSH) reported Increase (Decrease) in Derivative Liabilities of -$436.65 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2018-05-21
- Panacea Life Sciences Holdings, Inc. increase (decrease) in derivative liabilities for the quarter ending 2018-03-31 was -$436.65K.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in derivative liabilities for the quarter ending 2017-03-31 was $0.00.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month |
|---|---|
| 2018-03-31 | -$436.65K 10-Q · filed 2018-05-21 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-21 |